Now the Oxford AstraZeneca team, they've said that they're vaccine induces a good strong immune response in all adult age groups, including the over seventies, the most at risk group on, they say that's a key milestone, but that evidence hasn't been published yet.
現在,牛津阿斯利康團隊,他們已經說,他們的疫苗誘導一個很好的強大的免疫反應,在所有成人年齡組,包括70多歲,最危險的群體上,他們說,這是一個關鍵的里程碑,但證據還沒有公佈。